NautaDutilh Life Sciences Tuesdays: The new class action legislation: opportunity or threat?
Samen met hollanbio17/11/20
On 1 January 2020, the new class action legislation entered into force in the Netherlands. What does this mean for the pharmaceutical and medical devices industry? Should the industry brace itself for more claims and higher damages? Or should it be seen as a welcome dispute resolution tool, which can resolve legal disputes effectively? Not only the rules of the game changed, also the players: who may bring a suit, and who funds them? We will bring you fully up to speed on all developments!
Joe Braunreuther, Senior Litigation Counsel Johnson & Johnson
Rod Freeman, Partner Cooley
Koiji Fukumura, Partner Cooley
Stijn Franken, Partner NautaDutilh
Please register for one or more Life Sciences Tuesdays by filling in this registration form.
Get inspired by leaders and key players in the life sciences sector during the NautaDutilh Life Sciences Tuesdays. On 5 consecutive Tuesdays in November and December from 16:30 – 17.30 hours CET, we, in collaboration with global law firm Cooley and HollandBio, will host panels and workshops on 5 topics of relevance for companies, investors, advisors and other key players in the life sciences sector.
For more information about the various workshops, please click here.
